PAPER
Rapid Procedure for N-Phthaloylation
1987
MeCN) in A (0.1% TFA in H2O) for 20 min at a flow rate of 1.2 mL/
min with UV detection at 214 nm, except for GITC experiments
where a gradient of 20–50% of B in A was used with UV detection
at 250 nm. TLC was performed on aluminium sheets coated with
silica gel 60 F254 (Merck, Darmstadt) in hexanes–EtOAc–HOAc,
70:30:5.
13C NMR (50 MHz, DMSO-d6): = 33.7 (CH2), 54.2 (CH), 122.9
(CH), 126.3 (CH), 128.2 (CH), 128.6 (CH), 131.2 (C), 134.4 (CH),
137.7 (C), 167.4 (C), 169.6 (C).
MS: m/z = 295 (M+ + H), 317 (M+ + Na), 333 (M+ + K).
N -Phthaloyl-(S)-O-benzyltyrosinamide (4e).
White solid (1.38 g, 69%); mp 158 °C; Rf = 0.26; HPLC Rt = 15.18
min; [ ]D –162.1 (c = 1.0, MeOH).
1H NMR (200 MHz, DMSO-d6): = 3.41 (m, 2 H), 4.94 (dd, 1 H, J
= 11.7, 4.7 Hz), 5.0 (s, 2 H), 6.84 (d, 2 H , J = 8.6 Hz), 7.08 (d, 2 H,
J = 8.6 Hz), 7.33–7.43 (m, 6 H), 7.75 (s, 1 H), 7.85 (s, 4 H).
13C NMR (50 MHz, DMSO-d6): = 32.8 (CH2), 54.4 (CH), 68.9
(CH2), 114.5 (CH), 122.9 (CH), 127.5 (CH), 128.2 (CH), 129.5
(CH), 129.8 (C), 131.2 (C), 134.3 (CH), 136.9 (C), 156.8 (C), 167.4
(C), 169.6 (C).
N-Phthaloylation of -Amino Carboxamides and Dipeptides;
Typical Procedure
A solution of 2-(methoxycarbonyl)benzoic acid 1 (0.90 g, 5.0
mmol), -amino carboxamide, -amino ester or dipeptides 2 (5.0
mmol), BOP (2.26 g, 5.0 mmol), and i-Pr2NEt (3.4 mL, 20.0 mmol)
in CH3CN (40 mL) were stirred at r.t. for 30 min. A solution of
Na2CO3 (1.06 g, 10 mmol) in H2O (20 mL) was then added and stir-
ring was continued for 0.5–4 h (Table). After evaporation of the
CH3CN and dilution with EtOAc (100 mL), the organic phase was
washed with saturated NaHCO3 solution (3 50 mL), 1 N HCl (1
50 ml), H2O (1 50 mL), dried with Na2SO4, and evaporated to af-
ford the pure product in very good yield.
MS: m/z = 423 (M+ + Na), 439 (M+ + K).
EMM (m/z): [M + H]+ calcd for C24H20N2O4, 401.1501; found,
401.1510.
N -Phthaloyl-(S)-leucinamide (4a)
White solid (1.02 g, 78%); mp 160–161 °C; Rf = 0.37; HPLC Rt =
12.61 min; [ ]D –13.2 (c = 1.1, MeOH).
1H NMR (200 MHz, DMSO-d6): = 0.87 (d, 3 H, J = 6.6 Hz), 0.88
(d, 3 H, J = 6.5 Hz), 1.37 (m, 1 H), 1.90 (m, 1 H), 2.20 (m, 1 H),
4.67 (dd, 1 H, J =11.8, 4.3 Hz), 7.23 (s, 1 H), 7.62 (s, 1 H), 7.89 (m,
4 H).
N -Phthaloyl-(S)-valinamide (4f)
White solid (0.81 g, 66%); mp 194–195 °C; Rf = 0.36; HPLC Rt =
11.34 min; [ ]D –21.0 (c = 0.7, MeOH).
1H NMR (200 MHz, DMSO-d6): = 0.77 (d, 3 H, J = 6.8 Hz), 1.02
(d, 3 H, J = 6.7 Hz), 2.69 (m, 1 H), 4.29 (d, 1 H, J = 8.6 Hz), 7.11
(s, 1 H), 7.50 (s, 1 H), 7.88 (m, 4 H).
13C NMR (50 MHz, DMSO-d6): = 19.2 (CH3), 20.9 (CH3), 27.1
(CH), 58.4 (CH), 123.1 (CH), 131.3 (C), 134.5 (CH), 167.6 (C),
169.4 (C).
13C NMR (50 MHz, DMSO-d6): = 20.7 (CH3), 23.1 (CH3), 24.8
(CH), 36.5 (CH2), 51.3 (CH), 123.1 (CH), 131.5 (C), 134.4 (CH),
167.7 (C), 170.4 (C).
MS: m/z = 247 (M+ + H), 269 (M+ + Na), 285 (M+ + K).
MS: m/z = 261 (M+ + H), 283 (M+ + Na), 299 (M+ + K).
Benzyl N -Phthaloyl-(S)-valinate (4g)
Colourless oil (1.69 g, 100%); Rf = 0.70; HPLC Rt = 17.29 min; [ ]D
–47.4 (c = 1.0, MeOH).
N -Phthaloyl-(S)-iso-leucinamide (4b)
White solid (1.25 g, 96%); mp 227–228 °C; Rf = 0.41; HPLC Rt =
12.43 min; [ ]D +4.4 (c = 0.9, HOAc).
1H NMR (200 MHz, DMSO-d6): = 0.80 (d, 3 H, J = 6.8 Hz), 1.02
(d, 3 H, J = 6.7 Hz), 2.60 (m, 1 H), 4.62 (d, 1 H, J = 7.9 Hz), 5.09
(s, 2 H), 7.22 (s, 5 H), 7.86 (m, 4 H).
1H NMR (200 MHz, DMSO-d6): = 0.79 (t, 3 H, J = 7.1 Hz), 0.90
(m, 1 H), 0.99 (d, 3 H, J = 6.7 Hz), 1.38 (m, 1 H), 2.52 (m, 1 H),
4.36 (d, 1 H, J = 9.0 Hz), 7.14 (s, 1 H), 7.51 (s, 1 H), 7.89 (m, 4 H).
13C NMR (50 MHz, DMSO-d6): = 18.9 (CH3), 20.4 (CH3), 28.0
(CH), 56.9 (CH), 66.3 (CH2), 123.4 (CH), 127.6 (CH), 127.9 (CH),
128.2 (CH), 130.8 (C), 134.9 (CH), 135.4 (C), 167.3 (C), 168.1 (C).
13C NMR (50 MHz, DMSO-d6): = 10.6 (CH3), 16.6 (CH3), 25.2
(CH2), 32.8 (CH), 57.9 (CH), 123.1 (CH), 131.2 (C), 134.5 (CH),
167.6 (C), 169.5 (C).
MS: m/z = 360 (M+ + Na), 376 (M+ + K).
MS: m/z = 261 (M+ + H), 283 (M+ + Na), 299 (M+ + K).
EMM (m/z): [M + H]+ calcd for C20H19NO4, 338.1392; found,
338.1489.
N -Phthaloyl-(S)-O-benzylserinamide (4c)
White hygroscopic solid (1.27 g, 78%); Rf = 0.28; HPLC Rt = 13.12
min; [ ]D –32.1 (c = 1.0, MeOH).
1H NMR (200 MHz, CDCl3): = 3.88 (dd, 1 H, J = 6.0, 9.6 Hz),
4.39 (m, 1 H), 4.61 (d, 2 H, J = 4.0 Hz), 5.04 (dd, 1 H, J = 6.0, 8.7
Hz), 6.34 (s, 1 H), 6.89 (s, 1 H), 7.31 (s, 5 H), 7.67–7.85 (m, 4 H).
13C NMR (50 MHz, CDCl3): = 52.0 (CH), 67.6 (CH2), 73.4 (CH2),
123.6 (CH), 127.9 (CH), 128.1 (CH), 128.6 (CH), 131.8 (C), 134.3
(CH), 137.0 (C), 167.8 (C), 169.8 (C).
Methyl N -Phthaloyl-(S)-valinate (4h)
Colourless oil (1.15 g, 88%); Rf = 0.68; HPLC Rt = 15.00 min; [ ]D
–69.7 (c = 1.0, MeOH).
1H NMR (200 MHz, CDCl3): = 0.88 (d, 3 H, J = 6.8 Hz), 1.12 (d,
3 H, J = 6.7 Hz), 2.71 (m, 1 H), 3.68 (s, 3 H), 5.54 (d, 1 H, J = 8.3
Hz), 7.70–7.76 (m, 2 H), 7.77–7.87 (m, 2 H).
13C NMR (50 MHz, DMSO-d6): = 19.4 (CH3), 20.9 (CH3), 28.6
(CH), 52.4 (CH), 57.6 (CH3), 123.4 (CH), 131.7 (C), 134.2 (CH),
167.7 (C), 169.3 (C).
MS: m/z = 347 (M+ + Na), 363 (M+ + K).
EMM (m/z): [M + H]+ calcd for C18H16N2O4, 325.1188; found,
MS: m/z = 262 (M+ + H), 284 (M+ + Na).
325.1192.
t-Butyl N -Phthaloyl-(S)-alaninate (4i)
N -Phthaloyl-(S)-phenylalaninamide (4d)
White solid (1.34 g, 97%); mp 67–69 °C; Rf = 0.72; HPLC Rt =
15.79 min; [ ]D –10.3(c = 1.1, MeOH).
White solid (1.13 g, 77%); mp 226–228 °C; Rf = 0.27; HPLC Rt =
12.52 min; [ ]D –20.4 (c = 1.0, MeOH).
1H NMR (200 MHz, CDCl3): = 1.43 (s, 9 H), 1.64 (d, 3 H, J = 7.3
Hz), 4.87 (q, 1 H, J = 7.3 Hz), 7.70–7.88 (m, 4 H).
13C NMR (50 MHz, CDCl3): = 15.3 (CH3), 27.9 (CH3), 48.4 (CH),
82.3 (C), 123.4 (CH), 132.0 (C), 134.1 (CH), 167.6 (C), 168.7 (C).
1H NMR (200 MHz, DMSO-d6): = 3.34 (dd, 1 H, J = 14.0, 11.8
Hz), 3.53 (dd, 1 H, J = 14.0, 4.8 Hz), 4.93 (dd, 1 H, J =11.8, 4.8 Hz),
7.12 (m, 5 H), 7.32 (s, 1 H), 7.72 (s, 1 H), 7.80 (s, 4 H).
Synthesis 2001, No. 13, 1985–1988 ISSN 0039-7881 © Thieme Stuttgart · New York